LINC00520 Regulates VDAC1 Oligomerization to Promote Cisplatin Resistance in Lung Adenocarcinoma

Ziyao Wang, Bisong Chen, Desong Yang, Wei Xu, Jingwei Li, Chuyang Chen, Anbang Wu, Ping Xu, Li Fang, Yuejun Chen, Zheng Li

Open source

DOI
10.31083/fbl53197
Published
2026-10-10
Container
Frontiers in Bioscience-Landmark
Publisher
IMR Press
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.31083/fbl53197,
  title = {LINC00520 Regulates VDAC1 Oligomerization to Promote Cisplatin Resistance in Lung Adenocarcinoma},
  author = {Ziyao Wang and Bisong Chen and Desong Yang and Wei Xu and Jingwei Li and Chuyang Chen and Anbang Wu and Ping Xu and Li Fang and Yuejun Chen and Zheng Li},
  year = {2026},
  journal = {Frontiers in Bioscience-Landmark},
  doi = {10.31083/fbl53197},
  url = {https://doi.org/10.31083/fbl53197}
}

RIS

TY  - JOUR
TI  - LINC00520 Regulates VDAC1 Oligomerization to Promote Cisplatin Resistance in Lung Adenocarcinoma
AU  - Ziyao Wang
AU  - Bisong Chen
AU  - Desong Yang
AU  - Wei Xu
AU  - Jingwei Li
AU  - Chuyang Chen
AU  - Anbang Wu
AU  - Ping Xu
AU  - Li Fang
AU  - Yuejun Chen
AU  - Zheng Li
PY  - 2026
JO  - Frontiers in Bioscience-Landmark
DO  - 10.31083/fbl53197
UR  - https://doi.org/10.31083/fbl53197
ER  - 

APA

Wang, Z., Chen, B., Yang, D., Xu, W., Li, J., Chen, C., Wu, A., Xu, P., Fang, L., Chen, Y., & Li, Z. (2026). LINC00520 Regulates VDAC1 Oligomerization to Promote Cisplatin Resistance in Lung Adenocarcinoma. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl53197

Source records